[1] VA/DoD (2009) Clinical Practice Guideline for Management of Concussion/Mild Traumatic Brain Injury. Journal of Rehabilitation Research and Development, 46, 1-68.
https://doi.org/10.1682/JRRD.2008.03.0038
[2] Teasdale, G. and Jennett, B. (1974) Assessment of Coma and Impaired Consciousness: A Practical Scale. The Lancet, 304, 81-84. https://doi.org/10.1016/S0140-6736(74)91639-0
[3] Georgilis, K., Plomaritoglou, A., Dafni, U., Bassiakos, Y. and Vemmos, K. (1999) Aetiology of Fever in Patients with Acute Stroke. Journal of Internal Medicine, 246, 203-209.
https://doi.org/10.1046/j.1365-2796.1999.00539.x
[4] Roth, E.J., Love, L.L.L., Harvey, R.L., Heinemann, A.W., Semik, P. and Diaz, S. (2001) Incidence of and Risk Factors for Medical Complications during Stroke Rehabilitation. Stroke, 32, 523-529. https://doi.org/10.1161/01.STR.32.2.523
[5] Circiumaru, B., Baldock, G. and Cohen, J.A. (1999) Prospective Study of Fever in the Intensive Care Unit. Intensive Care Medicine, 25, 668-673. https://doi.org/10.1007/s001340050928
[6] Lakhan, S.E. and Pamplona, F. (2012) Application of Mild Therapeutic Hypothermia on Stroke: A Systematic Review and Meta-Analysis. Stroke Research and Treatment, 2012, Article ID: 295906. https://doi.org/10.1155/2012/295906
[7] Castillo, J., Dávalos, A., Marrugat, J. and Noya, M. (1998) Timing for Fever-Related Brain Damage in Acute Ischemic Stroke. Stroke, 29, 2455-2460.
https://doi.org/10.1161/01.STR.29.12.2455
[8] Sung, C.Y., Lee, T.H. and Chu, N.S. (2009) Central Hyperthermia in Acute Stroke. European Neurology, 62, 86-92. https://doi.org/10.1159/000222778
[9] Saper, C.B., Lu, J., Chou, T.C. and Gooley, J. (2005) The Hypothalamic Integrator for Circadian Rhythms. Trends in Neurosciences, 28, 152-157. https://doi.org/10.1016/j.tins.2004.12.009
[10] Crompton, M.R. (1971) Hypothalamic Lesions Following Closed Head Injury. Brain, 94, 165-172. https://doi.org/10.1093/brain/94.1.165
[11] Zimmerman, H. (1940) Temperature Disturbances and the Hypothalamus. Research Publications—Association for Research in Nervous and Mental Disease, 20, 824-840.
[12] Davison, C. (1940) Disturbances of Temperature Regulation in Man. Research Publications—Association for Research in Nervous and Mental Disease, 20, 774-823.
[13] Rango, M., Arighi, A., Airaghi, L. and Bresolin, N. (2012) Central Hyperthermia, Brain Hyperthermia and Low Hypothalamus Temperature. Clinical Autonomic Research, 22, 299-301. https://doi.org/10.1007/s10286-012-0174-6
[14] Bernheim, H., Block, L. and Atkins, E. (1979) Fever: Pathogenesis, Pathophysiology, and Purpose. Annals of Internal Medicine, 91, 261-270. https://doi.org/10.7326/0003-4819-91-2-261
[15] Badjatia, N. (2009) Fever Control in the Neuro-ICU: Why, Who, and When? Current Opinion in Critical Care, 15, 79-82. https://doi.org/10.1097/MCC.0b013e32832922e9
[16] Rincon, F., Patel, U., Schorr, C., Lee, E., Ross, S., Dellinger, R.P., et al. (2015) Brain Injury as a Risk Factor for Fever upon Admission to the Intensive Care Unit and Association with In-Hospital Case Fatality: A Matched Cohort Study. Journal of Intensive Care Medicine, 30, 107-114. https://doi.org/10.1177/0885066613508266
[17] Moltz, H. (1993) Fever: Causes and Consequences. Neuroscience & Biobehavioral Reviews, 17, 237-269.
[18] Fernandez, A., Schmidt, J., Claassen, J., Pavlicova, M., Huddleston, D., Kreiter, K., et al. (2007) Fever after Subarachnoid Hemorrhage Risk Factors and Impact on Outcome. Neurology, 68, 1013-1019. https://doi.org/10.1212/01.wnl.0000258543.45879.f5
[19] Saxena, M., Young, P., Pilcher, D., Bailey, M., Harrison, D., Bellomo, R., et al. (2015) Early Temperature and Mortality in Critically Ill Patients with Acute Neurological Diseases: Trauma and Stroke Differ from Infection. Intensive Care Medicine, 41, 823-832.
https://doi.org/10.1007/s00134-015-3676-6
[20] Diringer, M.N., Reaven, N.L., Funk, S.E. and Uman, G.C. (2004) Elevated Body Temperature Independently Contributes to Increased Length of Stay in Neurologic Intensive Care Unit Patients. Critical Care Medicine, 32, 1489-1495.
https://doi.org/10.1097/01.CCM.0000129484.61912.84
[21] Greer, D.M., Funk, S.E., Reaven, N.L., Ouzounelli, M. and Uman, G.C. (2008) Impact of Fever on Outcome in Patients with Stroke and Neurologic Injury. Stroke, 39, 3029-3035.
https://doi.org/10.1161/STROKEAHA.108.521583
[22] Olanow, C.W. and Koller, W.C. (1998) An Algorithm (Decision Tree) for Themanagement of Parkinson’s Disease Treatment Guidelines. Neurology, 50, S1-S88.
[23] McEvoy, G.K. (2000) AHFS Drug Information. American Society of Health-System Pharmacists.
[24] Yu, K.-W., Huang, Y.-H., Lin, C.-L., Hong, C.-Z. and Chou, L.-W. (2013) Effectively Managing Intractable Central Hyperthermia in a Stroke Patient by Bromocriptine: A Case Report. Neuropsychiatric Disease and Treatment, 9, 605.
[25] Samudra, N. and Figueroa, S. (2016) Intractable Central Hyperthermia in the Setting of Brainstem Hemorrhage. Therapeutic Hypothermia and Temperature Management, 6, 98-101. https://doi.org/10.1089/ther.2016.0004
[26] Meier, K. and Lee, K. (2017) Neurogenic Fever: Review of Pathophysiology, Evaluation, and Management. Journal of Intensive Care Medicine, 32, 124-129.
https://doi.org/10.1177/0885066615625194
[27] Rabinstein, A.A. (2007) Paroxysmal Sympathetic Hyperactivity in the Neurological Intensive Care Unit. Neurological Research, 29, 680-682. https://doi.org/10.1179/016164107X240071
[28] Deogaonkar, A., De Georgia, M., Bae, C., Abou-Chebl, A. and Andrefsky, J. (2005) Fever Is Associated with Third Ventricular Shift after Intracerebral Hemorrhage: Pathophysiologic Implications. Neurology India, 53, 202.
https://doi.org/10.4103/0028-3886.16411
[29] Kang, S.H., Kim, M.J., Shin, I.Y., Park, D.W., Sohn, J.W. and Yoon, Y.K. (2012) Bromocriptine for Control of Hyperthermia in a Patient with Mixed Autonomic Hyperactivity after Neurosurgery: A Case Report. Journal of Korean Medical Science, 27, 965-968.
https://doi.org/10.3346/jkms.2012.27.8.965
[30] Russo, R. and O’Flaherty, S. (2000) Bromocriptine for the Management of Autonomic Dysfunction after Severe Traumatic Brain Injury. Journal of Paediatrics and Child Health, 36, 283-285. https://doi.org/10.1046/j.1440-1754.2000.00485.x
[31] Bullard, D.E. (1987) Diencephalic Seizures: Responsiveness to Bromocriptine and Morphine. Annals of Neurology, 21, 609-611. https://doi.org/10.1002/ana.410210617
[32] Frenette, A.J., Kanji, S., Rees, L., Williamson, D.R., Perreault, M.M., Turgeon, A.F., et al. (2012) Efficacy and Safety of Dopamine Agonists in Traumatic Brain Injury: A Systematic Review of Randomized Controlled Trials. Journal of Neurotrauma, 29, 1-18.
https://doi.org/10.1089/neu.2011.1812
[33] Munakomi, S., Bhattarai, B. and Mohan Kumar, B. (2017) Role of Bromocriptine in Multi-Spectral Manifestations of Traumatic Brain Injury. Chinese Journal of Traumatology, 20, 84-86.
[34] Phelps, T.I., Bondi, C.O., Ahmed, R.H., Olugbade, Y.T. and Kline, A.E. (2015) Divergent Long-Term Consequences of Chronic Treatment with Haloperidol, Risperidone, and Bromocriptine on Traumatic Brain Injury-Induced Cognitive Deficits. Journal of Neurotrauma, 32, 590-597. https://doi.org/10.1089/neu.2014.3711